Orally administered glutathione is primarily absorbed in the intestine, while circulating glutathione is cleared by the kidneys, which leads to its poor absorption from the gastrointestinal tract
Glatter: In practice, many patients labeled non-responders to GLP-1 therapy are experiencing incomplete dosing, early discontinuation because of gastrointestinal side effects, insufficient treatment duration, or competing metabolic drivers such as severe insulin resistance, sleep disruption, sarcopenia, or medication-associated weight gain
None of us want to experience that torture
Because ALCAR has stimulating, energy-promoting properties, it is best to avoid taking doses late in the evening or right before bed, as it may interfere with sleep onset